Hiscox J A, Mawditt K L, Cavanagh D, Britton P
Division of Molecular Biology, Institute for Animal Health, Compton, Newbury, United Kingdom.
J Virol. 1995 Oct;69(10):6219-27. doi: 10.1128/JVI.69.10.6219-6227.1995.
The subgenomic mRNAs of the coronavirus transmissible gastroenteritis virus (TGEV) are not produced in equimolar amounts. We have developed a reporter gene system to investigate the control of this differential subgenomic mRNA synthesis. Transcription of mRNAs by the TGEV polymerase was obtained from negative-sense RNA templates generated in situ from DNA containing a T7 promoter. A series of gene cassettes was produced; these cassettes comprised the reporter chloramphenicol acetyltransferase (CAT) gene downstream of transcription-associated sequences (TASs) (also referred to as intergenic sequences and promoters) believed to be involved in the synthesis of TGEV subgenomic mRNAs 6 and 7. The gene cassettes were designed so that negative-sense RNA copies of the CAT gene with sequences complementary to the TGEV TASs, or modified versions, at the 3' end would be synthesized in situ by T7 RNA polymerase. Using this system, we have demonstrated that CAT was expressed from mRNAs derived from the T7-generated negative-sense RNA transcripts only in TGEV-infected cells and only from transcripts possessing a TGEV negative-sense TAS. Analysis of the CAT mRNAs showed the presence of the TGEV leader RNA sequence at the 5' end, in keeping with observations that all coronavirus mRNAs have a 5' leader sequence corresponding to the 5' end of the genomic RNA. Our results indicated that the CAT mRNAs were transcribed from the in situ-synthesized negative-sense RNA templates without the requirement of TGEV genomic 5' or 3' sequences on the T7-generated negative-sense transcripts (3'-TAS-CAT-5'). Modification of the TGEV TASs indicated (i) that the degree of potential base pairing between the 3' end of the leader RNA and the TGEV negative-sense TAS was not the sole determinant of the amount of subgenomic mRNA transcribed and (ii) that other factors, including nucleotides flanking the TAS, are involved in the regulation of transcription of TGEV subgenomic mRNAs.
冠状病毒传染性胃肠炎病毒(TGEV)的亚基因组mRNA并非以等摩尔量产生。我们开发了一种报告基因系统来研究这种亚基因组mRNA合成差异的调控机制。TGEV聚合酶对mRNA的转录是通过含有T7启动子的DNA原位产生的负链RNA模板实现的。构建了一系列基因盒;这些基因盒包含报告氯霉素乙酰转移酶(CAT)基因,该基因位于转录相关序列(TASs)(也称为基因间序列和启动子)的下游,据信这些序列参与TGEV亚基因组mRNA 6和7的合成。设计这些基因盒的目的是使T7 RNA聚合酶能原位合成CAT基因的负链RNA拷贝,其3'端带有与TGEV TASs互补的序列或修饰版本。利用该系统,我们证明只有在TGEV感染的细胞中,且只有从具有TGEV负链TAS的转录本中,CAT才能从T7产生的负链RNA转录本衍生的mRNA中表达。对CAT mRNA的分析表明其5'端存在TGEV前导RNA序列,这与所有冠状病毒mRNA都有一个对应于基因组RNA 5'端的5'前导序列的观察结果一致。我们的结果表明,CAT mRNA是从原位合成的负链RNA模板转录而来,而不需要T7产生的负链转录本(3'-TAS-CAT-5')上有TGEV基因组的5'或3'序列。对TGEV TASs的修饰表明:(i)前导RNA 3'端与TGEV负链TAS之间潜在碱基配对的程度并非转录的亚基因组mRNA量的唯一决定因素;(ii)其他因素,包括TAS两侧的核苷酸,参与了TGEV亚基因组mRNA转录的调控。